Literature DB >> 29414553

Cognitive and motor outcomes in children with unilateral Sturge-Weber syndrome: Effect of age at seizure onset and side of brain involvement.

Aimee F Luat1, Michael E Behen2, Harry T Chugani3, Csaba Juhász2.   

Abstract

PURPOSE: Most children with Sturge-Weber syndrome (SWS) develop seizures that may contribute to neurocognitive status. In this study, we tested the hypothesis that very early seizure onset has a particularly detrimental effect on the cognitive and/or motor outcomes of children with unilateral SWS. We also tested whether side of SWS brain involvement modulates the effect of seizure variables on the pattern of cognitive abnormalities.
METHODS: Thirty-four children (22 girls; mean age 6.1years) with unilateral SWS and history of epilepsy in a longitudinal cohort underwent neurological and cognitive evaluations. Global intelligent quotient (GIQ), verbal intelligent quotient (VIQ), nonverbal intelligent quotient (IQ), and motor function were correlated with epilepsy variables, side and extent of brain involvement on magnetic resonance imaging (MRI).
RESULTS: Mean age at seizure onset was 1.3years (0.1-6years) and mean IQ at follow-up was 86 (45-118). Age at seizure onset showed a logarithmic association with IQ, with maximum impact of seizures starting before age 1year, both in uni- and multivariate regression analyses. In the left SWS group (N=20), age at seizure onset was a strong predictor of nonverbal IQ (p=0.001); while early seizure onset in the right-hemispheric group had a more global effect on cognitive functions (p=0.02). High seizure frequency and long epilepsy duration also contributed to poor outcome IQ independently in multivariate correlations. Children with motor involvement started to have seizures at/before 7months of age, while frontal lobe involvement was the strongest predictor of motor deficit in a multivariate analysis (p=0.017).
CONCLUSION: These findings suggest that seizure onset prior to age 1year has a profound effect on severity of cognitive and motor dysfunction in children with SWS; however, the effect of seizures on the type of cognitive deficit is influenced by laterality of brain involvement.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive function; Epilepsy; Outcome; Seizure onset; Sturge–Weber syndrome

Mesh:

Year:  2018        PMID: 29414553      PMCID: PMC5845773          DOI: 10.1016/j.yebeh.2018.01.012

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  34 in total

Review 1.  Sturge-Weber syndrome and epilepsy: an argument for aggressive seizure management in these patients.

Authors:  Anne M Comi
Journal:  Expert Rev Neurother       Date:  2007-08       Impact factor: 4.618

Review 2.  Sensitive periods in the development of the brain and behavior.

Authors:  Eric I Knudsen
Journal:  J Cogn Neurosci       Date:  2004-10       Impact factor: 3.225

Review 3.  Normal development of brain circuits.

Authors:  Gregory Z Tau; Bradley S Peterson
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

4.  Outcome of infants with unilateral Sturge-Weber syndrome and early onset seizures.

Authors:  U Kramer; E Kahana; Z Shorer; B Ben-Zeev
Journal:  Dev Med Child Neurol       Date:  2000-11       Impact factor: 5.449

5.  Dynamic MR perfusion and proton MR spectroscopic imaging in Sturge-Weber syndrome: correlation with neurological symptoms.

Authors:  Doris D M Lin; Peter B Barker; Laura A Hatfield; Anne M Comi
Journal:  J Magn Reson Imaging       Date:  2006-08       Impact factor: 4.813

6.  Prophylactic antiepileptic treatment in Sturge-Weber disease.

Authors:  D Ville; O Enjolras; C Chiron; O Dulac
Journal:  Seizure       Date:  2002-04       Impact factor: 3.184

7.  Long-term effects of seizures in neonatal rats on spatial learning ability and N-methyl-D-aspartate receptor expression in the brain.

Authors:  Tao Bo; Yuwu Jiang; Haiyan Cao; Jingmin Wang; Xiru Wu
Journal:  Brain Res Dev Brain Res       Date:  2004-09-17

8.  Early seizure onset and dysplastic lesion extent independently disrupt cognitive networks.

Authors:  Brandon Korman; Pavel Krsek; Michael Duchowny; Bruno Maton; Esperanza Pacheco-Jacome; Gustavo Rey
Journal:  Neurology       Date:  2013-07-19       Impact factor: 9.910

9.  The natural history of epilepsy in tuberous sclerosis complex.

Authors:  Catherine J Chu-Shore; Philippe Major; Susana Camposano; David Muzykewicz; Elizabeth A Thiele
Journal:  Epilepsia       Date:  2009-12-22       Impact factor: 5.864

10.  Clinical and neuropsychological characteristics of pediatric epilepsy patients with atypical language dominance.

Authors:  U Gleissner; M Kurthen; R Sassen; S Kuczaty; C E Elger; D B Linke; H Urbach; C Helmstaedter
Journal:  Epilepsy Behav       Date:  2003-12       Impact factor: 2.937

View more
  4 in total

1.  Quality of Life in Children With Sturge-Weber Syndrome.

Authors:  Kelly A Harmon; Alyssa M Day; Adrienne M Hammill; Anna L Pinto; Charles E McCulloch; Anne M Comi
Journal:  Pediatr Neurol       Date:  2019-04-24       Impact factor: 3.372

2.  A case report of a pregnant woman with Sturge-Weber syndrome.

Authors:  Ying Luo; Yang Yang; Xiu Chen
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

3.  Study protocol: retrospectively mining multisite clinical data to presymptomatically predict seizure onset for individual patients with Sturge-Weber.

Authors:  Pooja Vedmurthy; Anna L R Pinto; Doris D M Lin; Anne M Comi; Yangming Ou
Journal:  BMJ Open       Date:  2022-02-04       Impact factor: 2.692

4.  Consensus Statement for the Management and Treatment of Sturge-Weber Syndrome: Neurology, Neuroimaging, and Ophthalmology Recommendations.

Authors:  Sara Sabeti; Karen L Ball; Sanjoy K Bhattacharya; Elena Bitrian; Lauren S Blieden; James D Brandt; Craig Burkhart; Harry T Chugani; Stephen J Falchek; Badal G Jain; Csaba Juhasz; Jeffrey A Loeb; Aimee Luat; Anna Pinto; Eric Segal; Jonathan Salvin; Kristen M Kelly
Journal:  Pediatr Neurol       Date:  2021-05-06       Impact factor: 4.210

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.